4//SEC Filing
Powl Brian T. 4
Accession 0001193125-25-283564
CIK 0001422143other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:00 PM ET
Size
6.3 KB
Accession
0001193125-25-283564
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Award
Common Stock
2025-11-13+48,900→ 148,576 total - Sale
Common Stock
2025-11-14$11.18/sh−8,887$99,329→ 139,689 total
Footnotes (2)
- [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest 50% immediately and 50% on 11/13/26.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 11/13/25.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001934232
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:00 PM ET
- Size
- 6.3 KB